Objectives:Growing evidence suggested that antiretroviral drugs (ARV) may promote β-amyloid accumulation in HIV-1-infected brain and the persistence of HIV-associated neurocognitive disorders (HAND). It has also been shown that lipid peroxidation upregulates β-site APP-cleaving enzyme 1 (BACE1) expression and subsequent promote β-amyloid peptide production. In the present study, we examined whether chronic exposure to the anti-HIV drugs tenofovir disoproxil fumarate and nevirapine induces lipid peroxidation thereby promoting BACE1 and β-amyloid generation and consequently impair cognitive function in mice.Methods:Tenofovir disoproxil fumarate or nevirapine were orally administered to female BALB/c mice once a day for 8 weeks. On the 7th week of treatment, spatial learning and memory were assessed using the Morris water maze test. The levels of lipid peroxidation, β-site APP cleaving enzyme 1 (BACE1), β-amyloid 1-42 and β-amyloid (Aβ) deposits were measured in the hippocampal tissue upon completion of treatment.Results:Chronic administration of nevirapine induced spatial learning and memory impairment in the Morris water maze test, whereas tenofovir disoproxil fumarate did not have an effect. Tenofovir disoproxil fumarate and nevirapine administration increased hippocampal lipid peroxidation and β-amyloid 1-42 concentration. Nevirapine further upregulated BACE1 expression and β-amyloid (Aβ) deposits.Conclusion:Our results suggest that chronic exposure to tenofovir disoproxil fumarate and nevirapine contributes to hippocampal lipid peroxidation and β-amyloid accumulation, respectively, as well as spatial learning and memory deficits in mice even in the absence HIV-infection. These findings further support a possible link between antiretroviral drug toxicity, β-amyloid accumulation and the persistence of HIV associated neurocognitive disorders.

Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice

Simola N.
Writing – Review & Editing
;
2020-01-01

Abstract

Objectives:Growing evidence suggested that antiretroviral drugs (ARV) may promote β-amyloid accumulation in HIV-1-infected brain and the persistence of HIV-associated neurocognitive disorders (HAND). It has also been shown that lipid peroxidation upregulates β-site APP-cleaving enzyme 1 (BACE1) expression and subsequent promote β-amyloid peptide production. In the present study, we examined whether chronic exposure to the anti-HIV drugs tenofovir disoproxil fumarate and nevirapine induces lipid peroxidation thereby promoting BACE1 and β-amyloid generation and consequently impair cognitive function in mice.Methods:Tenofovir disoproxil fumarate or nevirapine were orally administered to female BALB/c mice once a day for 8 weeks. On the 7th week of treatment, spatial learning and memory were assessed using the Morris water maze test. The levels of lipid peroxidation, β-site APP cleaving enzyme 1 (BACE1), β-amyloid 1-42 and β-amyloid (Aβ) deposits were measured in the hippocampal tissue upon completion of treatment.Results:Chronic administration of nevirapine induced spatial learning and memory impairment in the Morris water maze test, whereas tenofovir disoproxil fumarate did not have an effect. Tenofovir disoproxil fumarate and nevirapine administration increased hippocampal lipid peroxidation and β-amyloid 1-42 concentration. Nevirapine further upregulated BACE1 expression and β-amyloid (Aβ) deposits.Conclusion:Our results suggest that chronic exposure to tenofovir disoproxil fumarate and nevirapine contributes to hippocampal lipid peroxidation and β-amyloid accumulation, respectively, as well as spatial learning and memory deficits in mice even in the absence HIV-infection. These findings further support a possible link between antiretroviral drug toxicity, β-amyloid accumulation and the persistence of HIV associated neurocognitive disorders.
Amyloid
Beta-Secretase
HIV-Associated Cognitive Motor Complex
Keywords:
Oxidative stress
Reverse Transcriptase Inhibitors
File in questo prodotto:
File Dimensione Formato  
Zulu et al. 2020 Acta Neuropsychiatrica.pdf

Solo gestori archivio

Descrizione: Articolo principale
Tipologia: versione editoriale
Dimensione 568.52 kB
Formato Adobe PDF
568.52 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11584/292857
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact